KHN on the Air This Week
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
The independent source for health policy research, polling, and news.
281 - 300 of 601 Results
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.
Voting is a point of pride for many older Americans, and senior living facilities in past years have encouraged the civic act by hosting voting precincts, providing transportation to the polls and bringing in groups to help explain election issues. But fears of the spread of the coronavirus among this vulnerable population make voting more difficult this year.
President Donald Trump is one of at least two dozen people tied to the White House who have tested positive for COVID-19. Negotiations on the next round of COVID relief are off again — maybe. And the FDA and CDC continue to fight for scientific credibility. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Erin Mershon of Stat News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews Amy Howe of SCOTUSblog about what the Supreme Court might do with the latest case challenging the constitutionality of the Affordable Care Act.
During this, the first and only vice presidential debate of the 2020 election season, the two candidates clashed over the coronavirus and other health care issues, as well as a range of other topics.
The president’s doctors have used HIPAA — the Health Insurance Portability and Accountability Act — as a shield to avoid questions about the president’s COVID-19 diagnosis.
Montana’s Matt Rosendale and many other Republican congressional candidates face the challenge of convincing voters they support safeguards on preexisting conditions even as they oppose the Affordable Care Act, which codifies those safeguards.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
How will health issues affect voter choices? What will happen if President Donald Trump is reelected or the White House goes to Joe Biden? In this special election preview episode, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Tuesday night's presidential debate offered voters their first side-by-side comparison of the candidates, President Donald Trump and former Vice President Joe Biden.
The president entered office seeking to overturn the Affordable Care Act, revamp Medicaid and drive down prescription drug prices, among other things. He’s hit some stone walls.
The death of Supreme Court Justice Ruth Bader Ginsburg is giving new life to the latest constitutional challenge to the Affordable Care Act. It also places anti-abortion activists on the cusp of a court majority large enough to ensure the rollback of the right to abortion and, possibly, some types of birth control. Meanwhile, Health and Human Services Secretary Alex Azar tries to centralize power at the sprawling department plagued by miscommunications and scandals. Anna Edney of Bloomberg News, Kimberly Leonard of Business Insider and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Sarah Jane Tribble about her new podcast, “Where It Hurts,” debuting Sept. 29.
Few places loom as large in the race for the White House as here in Pinellas County, the largest swing county in the ultimate swing state. And polls show that many people will have the pandemic and its public health and economic consequences on their minds when they cast their votes.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
The Trump administration is primed to approve a plan designed to help lower costs of some prescription drugs by allowing states to import them from Canada. The announcement could come before Election Day, and Florida appears to be in line to go first.
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
Voters in Montana, Nebraska, South Dakota and several other conservative-leaning states will decide in November whether to legalize medical or recreational marijuana.
KHN senior Colorado correspondent Markian Hawryluk joined KUNC’s Erin O'Toole on “Colorado Edition” to discuss how the growing favorability of the Affordable Care Act could play a role in determining who wins control of the U.S. Senate this fall.
Donald Trump accepted his party's nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.
© 2026 KFF